Articles citing this paper
Recent advances in catalysts for the Henry reaction
Xuefei Bao
A B , Xu Li A , Chunfeng Jiang C * , Wei Xiao A * and Guoliang Chen B *
A Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, China.
B Key Laboratory of Structure-Based Drugs Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
C School of Biomedical and Chemical Engineering, Liaoning Institute of Science and Technology, Benxi, China.
Xuefei Bao was born in Liaoning, China, and received his PhD in Medicinal Chemistry from Shenyang Pharmaceutical University in 2018. Currently, he is working on his postdoctoral research under the supervision of Professor Guoliang Chen and Dr Wei Xiao in Shenyang Pharmaceutical University. His current research interests are the development of novel bioactive molecules against cancer, stroke and other conditions. |
Guoliang Chen was born in Hunan, China, and received his Master’s degree in Medicinal Chemistry from Shenyang Pharmaceutical University in 1993 and PhD in Medicinal Chemistry from Shenyang Pharmaceutical University in 2005. His current research interests include the development of novel bioactive molecules against cancer, neurodegenerative disease and other conditions. |
Handling Editor: Anastasios Polyzos
Australian Journal of Chemistry 75(10) 806-819 https://doi.org/10.1071/CH22136
Submitted: 14 June 2022 Accepted: 6 September 2022 Published: 8 November 2022
